MALAT1 and hepatocellular carcinoma: Given its upregulated expression in HCC, MALAT1 may prove to be a viable target, potentially with ASOs, due to its clear involvement in metastasis [117,144,145], which remains an unmet clinical need in HCC management [146,147].